메뉴 건너뛰기




Volumn 2, Issue 1, 2001, Pages 19-46

Antibody engineering for targeted therapy of cancer: Recombinant Fv-Immunotoxins

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIAL TOXIN; CELL MARKER; DIPHTHERIA TOXIN; FLUORINE 18; GROWTH FACTOR; HYBRID PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; IMMUNOTOXIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; IODINE 125; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 454A12; MONOCLONAL ANTIBODY B3; MONOCLONAL ANTIBODY BR96; MONOCLONAL ANTIBODY E23; PENICILLINASE; PRODRUG; PSEUDOMONAS EXOTOXIN; RECOMBINANT ANTIBODY; RECOMBINANT DNA; RICIN; RITUXIMAB; TOSITUMOMAB I 131; TRASTUZUMAB; UNCLASSIFIED DRUG;

EID: 0035030604     PISSN: 13892010     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389201013378824     Document Type: Article
Times cited : (23)

References (196)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.